Free Trial

KALA BIO (KALA) SEC Filings & 10K Form

KALA BIO logo
$6.80 +0.25 (+3.82%)
(As of 11/22/2024 ET)

Recent KALA BIO SEC Filings

DateFilerForm TypeView
09/25/2024
3:06 PM
KALA BIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
7:02 AM
KALA BIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
11:15 PM
KALA BIO (Filer)
Form EFFECT
07/31/2024
3:08 PM
KALA BIO (Filer)
Form 424B3
07/25/2024
3:10 PM
KALA BIO (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/17/2024
4:22 PM
KALA BIO (Subject)
Trachtenberg Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
4:34 PM
KALA BIO (Subject)
Trachtenberg Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/08/2024
7:54 PM
KALA BIO (Subject)
SR ONE CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D
06/28/2024
3:18 PM
KALA BIO (Filer)
Form D
Notice of Exempt Offering of Securities 
06/27/2024
7:00 PM
Brazzell Romulus K (Reporting)
KALA BIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:00 PM
Iwicki Mark T (Reporting)
KALA BIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:00 PM
KALA BIO (Issuer)
Reumuth Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:00 PM
KALA BIO (Issuer)
Kharabi Darius (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:00 PM
Bazemore Todd (Reporting)
KALA BIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
7:04 AM
KALA BIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
7:20 PM
Brazzell Romulus K (Reporting)
KALA BIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
7:21 PM
Iwicki Mark T (Reporting)
KALA BIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
7:22 PM
KALA BIO (Subject)
Reumuth Mary (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
7:23 PM
KALA BIO (Subject)
Kharabi Darius (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
7:23 PM
Bazemore Todd (Reporting)
KALA BIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
7:00 PM
Blumenkranz Mark S. (Reporting)
KALA BIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
7:00 PM
KALA BIO (Issuer)
KOVEN ANDREW I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
7:00 PM
KALA BIO (Issuer)
Myers C. Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
7:00 PM
KALA BIO (Issuer)
PERRY GREGORY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
7:00 PM
Farid Marjan (Reporting)
KALA BIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
7:00 PM
KALA BIO (Issuer)
Rosen Howard B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
7:00 PM
Iwicki Mark T (Reporting)
KALA BIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
7:00 PM
Brazzell Romulus K (Reporting)
KALA BIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
7:00 PM
KALA BIO (Issuer)
Reumuth Mary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
7:00 PM
KALA BIO (Issuer)
Kharabi Darius (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
7:00 PM
Bazemore Todd (Reporting)
KALA BIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:55 PM
Iwicki Mark T (Reporting)
KALA BIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2024
3:08 PM
KALA BIO (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:06 PM
KALA BIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
3:06 PM
KALA BIO (Filer)
Form 424B5
03/29/2024
7:21 AM
KALA BIO (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/29/2024
7:01 AM
KALA BIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
7:06 AM
KALA BIO (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
7:30 AM
KALA BIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
6:30 AM
KALA BIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
3:11 PM
KALA BIO (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
Buffett Dumps $982 Million in BofA Stock—What Does He Know? (Ad)

Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.

Get your FREE, no-obligation Wealth Protection Guide now
02/14/2024
12:09 PM
Checkpoint Capital L.P. (Filed by)
KALA BIO (Subject)
Form SC 13G/A
01/29/2024
3:36 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
KALA BIO (Subject)
Form SC 13G/A
01/05/2024
3:07 PM
KALA BIO (Issuer)
Trachtenberg Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
7:22 AM
KALA BIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KALA) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners